Clinical trials
Anemia trials in Brazil
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
44 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2001 | 1 |
| 2002 | 1 |
| 2004 | 4 |
| 2005 | 1 |
| 2006 | 5 |
| 2007 | 1 |
| 2008 | 1 |
| 2009 | 3 |
| 2012 | 3 |
| 2013 | 1 |
| 2014 | 1 |
| 2015 | 2 |
| 2016 | 5 |
| 2017 | 3 |
| 2018 | 2 |
| 2021 | 3 |
| 2023 | 1 |
| 2024 | 1 |
| 2025 | 2 |
| 2026 | 3 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Completed | 27 |
| Recruiting | 6 |
| Active, not recruiting | 4 |
| Unknown status | 4 |
| Terminated | 3 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Hoffmann-La Roche | 6 |
| Akebia Therapeutics | 4 |
| GlaxoSmithKline | 4 |
| Takeda | 4 |
| Novartis Pharmaceuticals | 3 |
| Amgen | 2 |
| Azidus Brasil | 2 |
| Johnson & Johnson Pharmaceutical Research & Development, L.L.C. | 2 |
| AstraZeneca | 1 |
| Bristol-Myers Squibb | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Anemia | 44 |
| Renal Insufficiency, Chronic | 9 |
| Renal Insufficiency | 4 |
| Anemia, Iron-Deficiency | 3 |
| Heart Failure | 3 |
| Hemoglobinuria, Paroxysmal | 3 |
| Myelodysplastic Syndromes | 3 |
| Primary Myelofibrosis | 3 |
| Cardiovascular Diseases | 2 |
| Red-Cell Aplasia, Pure | 2 |
Trials
Showing 76 to 44 of 44. Each trial links to its page on Pharma Observatory.
No trials match these filters.
Try a different keyword, or clear a filter.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.